These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26272554)

  • 1. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.
    Mifsud EJ; Tan AC; Reading PC; Jackson DC
    Immunol Cell Biol; 2016 Feb; 94(2):169-76. PubMed ID: 26272554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
    Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
    Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the impact of influenza-associated secondary pneumococcal infections.
    Mifsud EJ; Tan AC; Short KR; Brown LE; Chua BY; Jackson DC
    Immunol Cell Biol; 2016 Jan; 94(1):101-8. PubMed ID: 26134269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.
    Wu CC; Crain B; Yao S; Sabet M; Lao FS; Tawatao RI; Chan M; Smee DF; Julander JG; Cottam HB; Guiney DG; Corr M; Carson DA; Hayashi T
    J Innate Immun; 2014; 6(3):315-24. PubMed ID: 24192551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4.
    Wong EB; Mallet JF; Duarte J; Matar C; Ritz BW
    Nutr Res; 2014 Apr; 34(4):318-25. PubMed ID: 24774068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
    Deliyannis G; Wong CY; McQuilten HA; Bachem A; Clarke M; Jia X; Horrocks K; Zeng W; Girkin J; Scott NE; Londrigan SL; Reading PC; Bartlett NW; Kedzierska K; Brown LE; Mercuri F; Demaison C; Jackson DC; Chua BY
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33561017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Toll-Like Receptor 2 agonist PEG-Pam
    Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered live attenuated Salmonella Typhimurium protects mice against lethal infection with H1N1 influenza virus.
    Kamble NM; Hajam IA; Lee JH
    Vet Microbiol; 2017 Mar; 201():1-6. PubMed ID: 28284594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice.
    To EE; Erlich J; Liong F; Luong R; Liong S; Bozinovski S; Seow HJ; O'Leary JJ; Brooks DA; Vlahos R; Selemidis S
    Sci Rep; 2019 Feb; 9(1):2366. PubMed ID: 30787331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
    Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
    Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
    Schill T; Schön MP; Pletz N; Emmert S; Schön M
    Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
    Zeng W; Eriksson E; Chua B; Grollo L; Jackson DC
    Amino Acids; 2010 Jul; 39(2):471-80. PubMed ID: 20091415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
    Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
    Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages.
    Murphy EA; Davis JM; McClellan JL; Carmichael MD; Rooijen NV; Gangemi JD
    J Interferon Cytokine Res; 2011 Jun; 31(6):501-8. PubMed ID: 21352081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs.
    Dwivedi V; Manickam C; Dhakal S; Binjawadagi B; Ouyang K; Hiremath J; Khatri M; Hague JG; Lee CW; Renukaradhya GJ
    Vet Microbiol; 2016 Apr; 186():157-63. PubMed ID: 27016770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses.
    Jia W; Li H; He YW
    J Immunol; 2008 May; 180(9):6255-61. PubMed ID: 18424748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.
    Sun K; Ye J; Perez DR; Metzger DW
    J Immunol; 2011 Jan; 186(2):987-93. PubMed ID: 21160043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.